中和和结合抗体对SARS-CoV-2的反应在怀孕期间具有混合免疫力
Lin Li1,2, Yusuke Matsui3,4, Mary K Prahl5,6
1Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA.
NPJ vaccines
|August 27, 2024
概括
混合免疫,结合疫苗接种和感染,提高了孕妇的SARS-CoV-2抗体水平. 补充疫苗进一步增强了这些反应,有效地将抗体传递给胎儿.
科学领域:
- 免疫学 免疫学 免疫学
- 孕产妇和胎儿的健康
- 病毒学 病毒学
背景情况:
- 怀孕期间对SARS-CoV-2的混合免疫力仍未得到充分研究.
- 了解抗体反应对于母亲和婴儿健康至关重要.
研究的目的:
- 分析具有混合免疫力,接种疫苗或自然感染的孕妇中的中和结合抗体.
- 评估第三剂疫苗对抗体水平和母胎转移的影响.
主要方法:
- 中和抗体 (nAb) 和结合抗体的综合分析.
- 在接受mRNA疫苗接种,自然感染或两者同时接种的孕妇中,免疫反应的比较.
- 评估抗体的母胎转移效率.
主要成果:
- 第三次接种疫苗剂量显著增加了nAb水平,特别是在混合免疫中.
- 观察到抗Omicron nAb的减少,但保持了母胎传输效率.
- 疫苗诱导的nAbs显示出比感染诱导的nAbs更有效的转移.
- 与非怀孕对照组相比,怀孕减弱了IgA反应.
结论:
- 混合免疫和强制性疫苗接种增强了怀孕期间的幽默免疫反应.
- 抗体转移到胎儿是有效的,即使减少了Omicron特定的nAb.Ab.
- 数据支持孕妇群体通过混合免疫增强免疫反应.
相关概念视频
Cross-reactivity
31.0K
Overview
31.0K
Hybridoma Technology
14.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.2K
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Humoral Immune Responses
72.3K
Overview
72.3K
Development of Immunocompetence
295
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
295


